Get £1524 on Schizophrenia Study 225847

PAREXEL International Ltd.

UK Clinical Trials, clinical research harrow

The study is being carried out for the treatment of schizophrenia as well as cerebellar ataxia. The main purpose of the study is to see how safe the study drug is and how well it is tolerated after dosing.

Health Status: Healthy
Gender: Both
Ages: 18 to 55
BMI Range: 18 to 30

Inconvenience Allowance
Max Allowance: £1524
Screening Allowance: £0

To apply for this job please visit the following URL: →